H.R. 8432: To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes.
This bill aims to enhance the Food and Drug Administration's (FDA) ability to regulate human foods effectively. Here’s a breakdown of its main components:
1. Establishment of the Human Foods Innovation Account
The bill proposes the creation of a Human Foods Innovation Account to support various activities aimed at improving food safety and nutrition. The FDA would use this account for:
- Providing critical research grants
- Establishing a center of excellence related to human foods
- Creating partnerships with the private sector
- Developing modernized food standards, especially for infants and young children
- Enhancing food safety and supply chain reliability
- Encouraging nutrition innovation
- Strengthening dietary supplement regulations
- Conducting biotechnology research related to food
- Updating regulatory measures for food chemicals
- Improving risk assessment and decision-making in food regulation
- Increasing technical capacity for the FDA
- Implementing projects that promote innovation in the food sector
2. Creation of the Advisory Committee on Human Foods
A permanent Advisory Committee on Human Foods would be established to advise the Secretary of Health and Human Services on food science, nutrition, and food safety. This committee would consist of experts in these fields and representatives from various stakeholder groups, including consumers and health professionals.
3. Critical Research Grant Program
The FDA will have the authority to award competitive grants for research in critical areas pertaining to human foods, including:
- Food biotechnology
- Nutrition initiatives for better access to healthy foods
- Infant and maternal nutrition
- Health impacts of ultra-processed foods
- Safety of specialty foods like infant formula
- Health effects of dietary supplements
- Public understanding of nutrition-related risks and benefits
The Secretary will prioritize collaborative projects during these grant awards.
4. Establishment of the Center of Excellence
The FDA will create a center of excellence to focus on nutrition science and its connection to medicine. This center will coordinate efforts between the Human Foods Program and the Center for Drug Evaluation and Research, addressing areas such as:
- Use of medications for weight loss
- Managing allergic reactions through medical interventions
- The role of nutrition in overall health
- Programs supporting healthy eating in medical settings
5. Research Paperwork Adjustments
The bill proposes an exemption from certain paperwork requirements for the FDA when conducting voluntary research. This aims to streamline the research process.
6. Enhanced Recordkeeping for Processed Foods
Manufacturers of processed foods would be required to maintain detailed records relating to their recipes, including both labeled and non-labeled ingredients. The FDA would have the authority to access and review these records. If there are non-labeled ingredients, manufacturers must disclose these to the FDA, which would publish this information online.
7. Public-Private Partnerships
The FDA would enter into partnerships with private sector entities to promote information sharing regarding food packaging materials and to establish chemical limits in foods. Reports on the outcomes of these collaborations would be submitted to Congress annually.
Relevant Companies
- MDLZ - Mondelez International may be impacted due to increased requirements for transparency in food ingredients and chemicals in their products.
- KR - The Kroger Company could be affected by changes in food safety regulations and requirements for detailed recordkeeping of processed foods.
- PG - Procter & Gamble may face new guidelines related to food safety and packaging materials as they produce a range of items that include food-related products.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Apr. 22, 2026 | Introduced in House |
| Apr. 22, 2026 | Referred to the House Committee on Energy and Commerce. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.